Skip to main content
Table of Contents
Print

Does Cannabis Stabilise Respiratory Central Control in Sleep Apnoea? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Sleep apnoea is characterised by unstable breathing due to impaired central respiratory regulation. Recent studies investigate whether cannabis for respiratory control can enhance ventilatory stability, potentially reducing apnoea-hypopnoea events and improving sleep quality. 

Central Respiratory Regulation 

Evidence suggests that cannabis for respiratory control may influence neural pathways responsible for central respiratory regulation. Modulating these pathways could support more consistent breathing patterns during sleep. 

Ventilatory Stability with Cannabinoids 

Research indicates that cannabinoids may improve ventilatory stability with cannabinoids, helping maintain steady oxygen and carbon dioxide levels, and reducing abrupt respiratory interruptions common in obstructive sleep apnoea. 

Central Nervous System Effects 

By acting on receptors in the brainstem, cannabis for respiratory control could stabilise central respiratory signals, improving the timing and strength of respiratory efforts during sleep. 

Potential Therapeutic Impact 

Enhanced central respiratory regulation may reduce the frequency and severity of apnoea episodes, improve sleep architecture, and mitigate daytime fatigue associated with OSA. 

Current evidence suggests that cannabis for respiratory control shows promise in stabilising breathing through ventilatory stability with cannabinoids and improved central respiratory regulation. Further clinical trials are needed to validate its effectiveness and safety for long-term use in sleep apnoea management. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories